OpenSAFELY Jobs
OpenSAFELY Jobs provides an audit trail for every project using the OpenSAFELY platform. It logs all activity that uses real patient data. It includes links to all the analytic code ever run, and all published outputs.
Authorised users can use this site to manage their projects and trigger their code to run in one of the secure environments.
Why OpenSAFELY?
Better research, improved patient confidentiality
OpenSAFELY is a highly secure, transparent, open-source software platform for analysis of electronic health records data.
-
Protecting privacy
- We never let researchers download patient data, and OpenSAFELY tools let users to write code to analyse patient data without even needing to view the raw records.
-
Auditable by the public
- It is a privilege to use patient data for the public good. OpenSAFELY respects patients by carefully considering this in every part of its design.
-
Better, open science
- OpenSAFELY requires publication of all analytic code, and our tools drive all users to produce prespecified, reusable, testable, shareable and modular software for research.
-
Enabling high volumes of research
- Over 25 organisations have used OpenSAFELY to create published research.
Working In Partnership With
Latest job requests
Most recent job requests on the OpenSAFELY platform
| Status | Organisation | Project | User | Started | View request |
|---|---|---|---|---|---|
| Unknown | Bennett Institute | OpenSAFELY Internal | Becky Smith | - | View, Job request 23593 |
| Failed | The London School of Hygiene & Tropical Medicine | Long-term kidney outcomes after SARS-CoV-2 infection | Viyaasan Mahalingasivam | 30 Jun 2024 at 20:26 | View, Job request 23592 |
| Failed | The London School of Hygiene & Tropical Medicine | Long-term kidney outcomes after SARS-CoV-2 infection | Viyaasan Mahalingasivam | 30 Jun 2024 at 08:04 | View, Job request 23591 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | Qing Wen | 29 Jun 2024 at 06:39 | View, Job request 23590 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | Qing Wen | 28 Jun 2024 at 22:59 | View, Job request 23589 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | Qing Wen | 28 Jun 2024 at 22:18 | View, Job request 23588 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | Qing Wen | 28 Jun 2024 at 19:23 | View, Job request 23587 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | Bang Zheng | 28 Jun 2024 at 15:42 | View, Job request 23586 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | Bang Zheng | 28 Jun 2024 at 15:08 | View, Job request 23585 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | Bang Zheng | 28 Jun 2024 at 14:26 | View, Job request 23584 |